Krangel M S, Taketani S, Biddison W E, Strong D M, Strominger J L
Biochemistry. 1982 Nov 23;21(24):6313-21. doi: 10.1021/bi00267a042.
Comparative primary structural analyses have begun to elucidate polymorphic residues and segments of the class I antigens of the major histocompatibility complex, at least some of which presumably contribute to determinants important in immune recognition events. HLA-A2 structural variants have been described which are serologically indistinguishable from other HLA-A2 antigens, yet which can be recognized neither by HLA-A2 specific alloimmune nor by HLA-A2 restricted, virus immune cytotoxic T lymphocytes. This study utilizes double-label tryptic peptide comparisons in combination with both conventional and microsequence analyses to investigate the structure of two such variants, M7 and DR1. We find that these variants are identical with each other and differ from the predominant HLA-A2 heavy chain species by a glutamine to arginine substitution at residue 43, by an unidentified substitution in the tryptic peptide spanning residues 147-157, and by an as yet poorly defined alteration in glycosylation. Structural information from these and other variants should be useful in precisely defining functionally important determinants on the molecule.
比较一级结构分析已开始阐明主要组织相容性复合体 I 类抗原的多态性残基和片段,其中至少一些可能对免疫识别事件中重要的决定簇有贡献。已描述了 HLA - A2 结构变体,它们在血清学上与其他 HLA - A2 抗原无法区分,但既不能被 HLA - A2 特异性同种免疫细胞识别,也不能被 HLA - A2 限制性病毒免疫细胞毒性 T 淋巴细胞识别。本研究利用双标记胰蛋白酶肽比较结合传统和微序列分析来研究两种这样的变体 M7 和 DR1 的结构。我们发现这些变体彼此相同,并且与主要的 HLA - A2 重链种类不同,在第 43 位残基处谷氨酰胺被精氨酸取代,在跨越 147 - 157 位残基的胰蛋白酶肽中有一个未确定的取代,以及在糖基化方面有一个尚未明确界定的改变。来自这些和其他变体的结构信息对于精确界定分子上功能重要的决定簇应该是有用的。